Skip to content

the effect of combined herbal capsule on covid-19 disease

The effect of combined capsule black pepper ?sativa linn )black cumin) and Curcuma Longa on inflammation factors and lipid profiles and acute phase proteins in patients with covid-19 hospitalized

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210804052068N1
Enrollment
30
Registered
2021-11-23
Start date
2021-11-22
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19 disease.

Interventions

Intervention 1: Intervention group: Patients consuming herbal capsules of a combination of black pepper, black seed and turmeric. Intervention 2: Control group: Patients taking placebo containing caps

Sponsors

Shooshtar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients admitted to covid-19 wards of the hospital positive pcr test Age range 20 to 70 years Willingness to participate in the study

Exclusion criteria

Exclusion criteria: The patient avoids taking the capsule changing the type and amount of medication taken during the intervention Any changes in treatment plan and disease conditions Chronic diseases such as diabetes, hypertension, cancer, obesity (body mass index above 30) History of drug and food allergies Transfer the patient to the intensive care unit ??? ????? ?? ????? ?????? ?? ??????

Design outcomes

Primary

MeasureTime frame
Age, history of disease, history of use of immunosuppressive drugs, sex, level of education, length of hospital stay, economic status, blood lipids, blood interleukins, hs-CRP. Timepoint: From the first of November 2021to the first of July 2022. Method of measurement: the studied markers are measured by spectrophotometric and ELISA methods.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactsima hashemi

Shooshtar University of Medical Sciences

simahashemi8491@gmail.com+98 61 3622 8926

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026